ArticlePDF Available

Minimally Invasive Surgical Repair of Vertebral Artery Ostium Stenosis in Patients with Ischemic Stroke: A Single-Center Case Series

Authors:
  • Zan Mitrev Clinic

Abstract and Figures

Background Ischemic stroke is the second leading cause of death in North Macedonia. Posterior circulation disease, caused by vertebral artery (VA) ostium (VAo) stenosis, is a common cause of ischemic stroke. We established a treatment approach using surgical revascularization of posterior circulation disease. In the present observational study, we assessed the outcome after surgical revascularization of the posterior circulation ischemia caused by VAo stenosis. Methods A retrospective analysis of 20 consecutive patients who had undergone surgery from January 2017 to December 2019. The VA was accessed through a 3-cm incision in the upper medial clavicle. The corrective procedures consisted of resection and anastomosis (15 of 20), VA to subclavian artery transposition (16 of 20), endarterectomy (10 of 20), vein graft interposition techniques (4 of 20), and vein graft bypass (1 of 20). Results The cohort included 9 acute cases. The mean patient age was 66.5 years (range 46–77). Of the 20 patients, 8 were women and 12 were men. Left-sided VA pathology was present in 75% of the cases. We observed rapid clinical improvement in 19 patients (95%). The total study period was 321 patient-months, with a median follow-up of 18 months (interquartile range, 5–24 months). One patient had died of an unknown cause after 12 months. During the follow-up period, 15 patients (75%) had reported permanent clinical improvement with no significant relapse of symptoms. Conclusions Minimally invasive surgical revascularization of the posterior brain circulation is a clinically effective therapeutic approach to manage ischemia caused by VAo stenosis. It can be performed safely, promote long-lasting symptom relief, and prevent recurrent strokes.
Content may be subject to copyright.
Minimally Invasive Surgical Repair of Vertebral Artery Ostium Stenosis in Patients with
Ischemic Stroke: A Single-Center Case Series
Riste Zimoski
1
, Petar Ugurov
1
, Lidija Veljanoska-Kiridjievska
1
, Nikola Hristov
1
, Enver Idoski
1
, Marko Gjorgon
1
,
Neda Milevska-Kostova
2
, Rodney Alexander Rosalia
1,3
, Zan Mitrev
1
-BACKGROUND: Ischemic stroke is the second leading
cause of death in North Macedonia. Posterior circulation
disease, caused by vertebral artery (VA) ostium (VAo) steno-
sis, is a common cause of ischemic stroke. We established a
treatment approach using surgical revascularization of pos-
terior circulation disease. In the present observational study,
we assessed the outcome after surgical revascularization of
the posterior circulation ischemia caused by VAo stenosis.
-METHODS: A retrospective analysis of 20 consecutive
patients who had undergone surgery from January 2017 to
December 2019. The VA was accessed through a 3-cm
incision in the upper medial clavicle. The corrective pro-
cedures consisted of resection and anastomosis (15 of 20),
VA to subclavian artery transposition (16 of 20), endarter-
ectomy (10 of 20), vein graft interposition techniques (4 of
20), and vein graft bypass (1 of 20).
-RESULTS: The cohort included 9 acute cases. The mean
patient age was 66.5 years (range 46e77). Of the 20 pa-
tients, 8 were women and 12 were men. Left-sided VA
pathology was present in 75% of the cases. We observed
rapid clinical improvement in 19 patients (95%). The total
study period was 321 patient-months, with a median
follow-up of 18 months (interquartile range, 5e24 months).
One patient had died of an unknown cause after 12 months.
During the follow-up period, 15 patients (75%) had reported
permanent clinical improvement with no significant
relapse of symptoms.
-CONCLUSIONS: Minimally invasive surgical revascu-
larization of the posterior brain circulation is a clinically
effective therapeutic approach to manage ischemia caused
by VAo stenosis. It can be performed safely, promote long-
lasting symptom relief, and prevent recurrent strokes.
INTRODUCTION
The global burden of disease study conducted in 2017 re-
ported alarming data for North Macedonia.
1
More people in
North Macedonia die of strokes than of any other cause,
with ischemic stroke representing the second leading cause of
death and disability.
2,3
Nevertheless, neither government policies
nor national guidelines have been established regarding provision
of a stroke service.
4
In the absence of a national stroke program,
we have established a prevention and treatment approach based
on surgical revascularization that targets the posterior circulation
ischemia in particular.
5
The posterior circulation is supplied by the vertebral arteries
(VAs). Posterior circulation disease (PCD) will be observed in
Key words
-Extracranial
-Minimally invasive surgery
-Posterior circulation disease
-Vertebral artery
Abbreviations and Acronyms
CT: Computed tomography
CTA: Computed tomography angiography
CVI: Cerebrovascular insult
IQR: Interquartile range
PCD: Posterior circulation disease
SV: Saphenous vein
TIA: Transient ischemic attack
VA: Vertebral Artery
VAo: Vertebral artery ostium
From the
1
Department of Cardiovascular Surgery, Zan Mitrev Clinic; and
2
Institute for Social
Innovation, Skopje, Republic of North Macedonia; and
3
Maastricht School of Management,
Maastricht, The Netherlands
To whom correspondence should be addressed: Zan Mitrev, M.D.
[E-mail: zan@zmc.mk]
Supplementary digital content available online.
Riste Zimoski, Petar Ugurov, Rodney Rosalia, and Zan Mitrev contributed equally to the
present study.
Citation: World Neurosurg. (2020).
https://doi.org/10.1016/j.wneu.2020.11.041
Journal homepage: www.journals.elsevier.com/world-neurosurgery
Available online: www.sciencedirect.com
1878-8750/ª2020 The Authors. Published by Elsevier Inc. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 1
Doing More with Less
20%e40% of cases of stroke.
6
The ow characteristics and
morphology of the subclavian artery and VA predispose to the
formation of atherosclerotic lesions at the VA ostium (VAo).
Thus, the VAo and the proximal segment (V1) are the most
common sites of stenosis observed in patients after
ischemic stroke resulting from posterior circulation
insufciency.
6-10
Posterior circulation stroke causes
awiderangeofnonspecic presenting symptoms;
thus,misdiagnosisiscommon.
11
PCD caused by VAo stenosis often manifests as a
medically refractory condition requiring intervention.
The optimal treatment of VAo stenosis is ill-dened.
However, long-term clinical benet likely requires complete
removal of ostial plaques, which will often extend deep into the
subclavian artery.
12
Despite the clinical benets associated with endovascular
treatment approaches for PCD, stenting for VAo stenosis is
infrequently performed in North Macedonia because of limited
nationwide expertise with VA stenting. In our attempt to
compensate for the limited experience with VA endovascular
interventions and to provide a durable, clinically effective
treatment alternative, we have established an open surgical
repair technique to treat VAo stenosis and posterior circulation
ischemia. Surgery has the potential to offer sustained, relapse-
free postoperative clinical outcomes comparable to those with
endovascular procedures.
13,14
However, the approach is rarely
performed owing to the complexity, perceived risks, and high
rate of complications.
15
In the present report, we have
described our experience with surgical correction of the
proximal VA in the management of ischemic strokes
attributable to PCD.
METHODS
Study Cohort
The study case series included 20 consecutive patients who had
undergone surgery on the VA under general anesthesia from 2017
to 2019. Data were collected prospectively using the electronic
health records and analyzed retrospectively. The primary
endpoint was a debilitating stroke in the rst 30 days after
discharge. The secondary endpoints were operative mortality,
16
mid-term all-cause mortality, ischemic stroke during the
follow-up period, target vessel revascularization, and symptom
relapse.
The decision to perform surgery was determined by the pres-
ence of persistent neurological symptoms (>3 months), despite
adequate rst-line medical therapy, combined with a history of
ischemic events, conrmed ischemic zones on computed to-
mography (CT) of the brain, >50% stenosis in both VAs, and/or
>60% unilateral stenosis in the dominant VA.
17
Asymptomatic
patients with severe or critical disease with 70% VAo stenosis
in the dominant artery discovered incidentally were informed of
their high risk of stroke and advised to undergo invasive
treatment.
The ethical committee of the hospital approved the present
observational study.
18
Diagnostic Approach
All patients were diagnosed according to their clinical
symptoms and CT angiography (CTA) ndings of the
vertebrobasilar area.
Surgical Technique
We used a minimally invasive approach for the surgery
(Video 1). In brief, the patients were sedated and
placed under general anesthesia. We intubated the
patients 30e60 minutes before surgery and extubated them
during the 30e120 minutes of postoperative recovery in the
intensive care unit.
Intraoperative monitoring was performed via 5-lead electrocardi-
ography, noninvasive blood pressure, pulse oximetry, and peripheral
insertion of an 18-gauge intravenous cannula. In addition, a 20-gauge
cannula was placed in the contralateral radial artery for continuous
invasive blood pressure monitoring. We monitored the cerebral
oxygenation and circulation using near-infrared spectroscopy.
The patients head was placed in a supine position with slight
hyperextension and contralateral rotation. The VA lesion site was
accessed via a 3-cm inclined incision in the upper medial clavicle,
followed by cutting the platysma. Special care was taken not to
injure the thoracic duct when performing surgery on the left VA.
The lateral head of the sternocleidomastoid muscle was dissected,
followed by visualizing the phrenic nerve, which was isolated
medially to liberate space to cut the anterior scalene muscle.
Resection of the anterior scalene muscle allowed for access and
evaluation of the subclavian artery, which is mobilized medially.
Several lateral branches were ligated next to enable visualization of
the origin of the VA. Approximately 10 minutes before clamping of
any of the major vessels, we administered 4000e10,000 IU of
heparin to establish an activated clotting time of >300 seconds.
The VA was anatomically characterized by the lack of branches
in the proximal segment. Once identied, the VA was isolated,
liberated from any adhesions, and mobilized. The subclavian ar-
tery was clamped proximally and distally with vascular clamps,
and the VA was clamped with a bulldog clamp. The VA was
transected at its origin, and several corrective procedures were
performed as indicated by the lesion characteristics.
19-24
Endarterectomy. Endarterectomy and reimplantation of the prox-
imal VA are established vascular procedures (Figure 1). We
routinely inspected the lumen of the subclavian artery for
abnormalities. The vessel was irrigated with heparinized saline.
Decalcication and endarterectomy were performed, if necessary.
Transposition. The VA artery was transposed to the subclavian
artery via a terminalelateral anastomosis (Figure 1). We used 8-0
Prolene suture for the anastomosis. Before full closure of the
suture line, the distal subclavian artery was unclamped and de-
aired by back-bleeding.
Video available at
www.sciencedirect.com
2www.SCIENCEDIRECT.com WORLD NEUROSURGERY,https://doi.org/10.1016/j.wneu.2020.11.041
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 3
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
Bypass. The saphenous vein (SV) was used as the conduit for the
subclavian artery to VA bypass, which was performed using
interposition techniques as previously described. In brief, the SV
was exposed at the medial aspect of the knee and thigh. The vein
was ligated next, and its lumen was ushed and distended with
heparinized saline solution. We harvested ~5e10 cm in length.
On exposure of the VA, we prepared the subclavian artery as an
inow for a bypass graft. The VA was clampedith 2 clips, and next
VA was incised, followed by continuous anastomosis with the SV
graft in a side-to-end fashion, using 8-0 Prolene sutures. Next, we
clamped the subclavian artery at a proximal and distal site around
the area planned for the arteriotomy. The cut was made using a
no. 11 blade and completed with a 4-mm diameter arteriotomy
punch. Subsequently, an end-to-side anastomosis was performed
with the SV graft using continuous 7-0 Prolene sutures to the
subclavian artery in the same manner.
Interposition. The exposure, identication, and isolation of the
subclavian artery and VA were performed as described previously.
The occluded section of the VA was identied. Using the harvested
SV, we performed a side-to-end anastomosis on a proximal part of
the subclavian artery using a 7-0 running Prolene suture. The
distal part of the graft was connected to the VA via an end-to-end
anastomosis using 8-0 Prolene suture.
The arterial clamps were released, a drainage tube was placed in
the surgical site, and the wound was closed. Finally, heparin-
ization was nullied by the administration of 2500e5000 IU of
protamine to achieve an activated clotting time of <160 seconds.
Statistical Analysis
We used Prism, version 8.3.1 (GraphPad, San Diego, California,
USA), for statistical analysis. The DAgostino and Pearson
normality test was used to assess continuous data distribution.
Categorical data are presented as the number of events per the
total number with percentages. Continuous data are presented as
the mean standard deviation or median and interquartile range
(IQR). The Fisher exact test was used to compare categorical
variables. We determined survival and freedom-from-reoperation
using the Kaplan-Meier method. Patients were censored at the
last conrmed date of patientephysician contact or telephone
follow-up.
RESULTS
Demographics and Clinical Characteristics
The patient demographics and clinical characteristics are pre-
sented in Table 1. The mean age of the cohort was 66.5 years. Most
of the patients were overweight; 7 had presented with a body mass
index >30 kg/m
2
. Other prominent comorbidities were
hypertension (100%), hyperlipidemia (90%), and type 2 diabetes
mellitus (30%). Three patients had presented with peripheral
artery disease and ve (25.0%) with conrmed coronary artery
disease. Two patients had a history of myocardial infarction.
The predominant symptoms at admission were vertigo (80%),
ataxia (25%), and syncope (20%). One asymptomatic patient with a
history of transient ischemic attack (TIA) was treated after obser-
vation of hypodense zones on the patients CT scans of the brain
during assessment for elective cardiac surgery. He was considered
at high risk for recurrent cerebrovascular insult (CVI)/TIA because
of the presence of soft plaque atherosclerosis at the VAo.
The active medical treatments at admission are described in
Table 2. Despite ongoing medical therapy, the patients reported
not experiencing a decrease in symptom severity. The CTA
examinations (Figure 2) revealed unilateral left- and right-sided
lesions in 9 patients (45.0%) and 5 patients (25.0%), respec-
tively, with bilateral VAo/V1 lesions in 5 patients. For the patients
with bilateral lesions, we rst targeted the dominant VA.
The corrective surgical approaches are presented in Table 3.We
mainly performed complete resection of the stenotic lesions
combined with VA to subclavian artery transposition and
terminalelateral anastomosis. Other procedures included endar-
terectomy, graft interposition techniques, and 1 case of vein
bypass grafting.
Early Clinical Outcomes
The surgery duration was, on average, 70.2 16.8 minutes. The
patients had required 3.29 hours (IQR, 2.85e3.79 hours) of me-
chanical respiratory support. The postoperative intensive care unit
length of stay was 4.7 hours (IQR, 3.9e16.5 hours), and the
average hospital stay was 2 days (IQR, 2e3 days).
Surgery resulted in direct clinical success for 19 of 20 patients
(95.0%), leading to immediate symptom relief. CTA follow-up
analysis was available for 14 patients (70.0%). In this subgroup,
adequate VA patency was conrmed. The case of a patient with an
occluded right VA treated at our clinic is shown in Figure 2BeE.
Adequate graft patency was conrmed after surgical
revascularization. The 30-day follow-up data were complete for
all but 1 patient. The latter patient had not presented for her
postoperative follow-up visit. She had relocated after the surgery
and changed her telephone number and contact details without
informing us.
No patient had died early in the follow-up period. One woman
who had previously undergone coronary artery bypass grafting and
left carotid artery endarterectomy had experienced persisting
symptoms due to de novo atherosclerotic lesions in the carotid
arteries. Medical therapy was insufcient to mitigate the symp-
toms, and she successfully underwent a second surgery on the left
common and internal carotid arteries after 9 months. We inter-
viewed her 18 months after the index VA surgery. Her clinical
condition was suboptimal with high blood pressure, and she was
experiencing bouts of dizziness. One male patient had required
second surgery on the contralateral VA. We performed
Figure 1. Intraoperative images showing open surgical repair on the dominant right stenotic vertebral artery ostium of a 69-year-old man who had
presented with recent transient ischemic attack and a history of stroke attributed to bilateral vertebral artery ostium stenoses. (A) Assessing and
determining the position of the cut; (B) cutting the skin and subcutaneous tissue; (CeG) preparation of the tissue and visualiza tion and mobilization
of the subclavian artery; (H, I) visualization and mobilization of the vertebral artery; (J) placement of the clamps; (KeO) resection of the vertebral
artery, endarterectomy, and anastomosis; (P, Q) hemostasis control; (R, S) placement of the drainage tube; and (T, U) closure of the wound.
4www.SCIENCEDIRECT.com WORLD NEUROSURGERY,https://doi.org/10.1016/j.wneu.2020.11.041
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
endarterectomy and longitudinal, transverse resection of the right
subclavian artery and VA arterioplasty with the subclavian artery
(Figure 2FeI).
Mid-Term Follow-Up
The total follow-up period was 321 patient-months, with a median
follow-up of 18 months (IQR, 5e24 months; Figure 3A). No
conrmed cases of stroke or other debilitating neurological
events related to the index VAo/V1 surgery had occurred. Of the
20 patients, 16 (80.0%) reported durable symptom resolution
with no signicant relapse of neurological symptoms. Of the 4
patients with symptom relapse, 2 had successfully undergone
surgery of carotid artery stenosis, which had manifesting as
new-onset vertigo. One of the 2 patients, a man who had under-
gone reoperation 4 months after the index surgery, had died of an
unknown cause 8 months after the second surgery. However, his
relatives were unwilling to disclose the cause of death.
During the whole study period, 6 patients were readmitted for
other cardiovascular interventions or surgery (Figure 2B). One
patient with coronary artery disease who had undergone
coronary artery bypass grafting 5 years before the index VA
surgery was then admitted twice within 3 months because of
paroxysmal supraventricular tachycardia and on a subsequent
occasion because of paroxysmal atrial brillation. These events
were managed successfully with antiarrhythmic therapy.
DISCUSSION
In North Macedonia, more people die of stroke than of any other
cause
3
(Supplementary Figure 1). A global comparison, using a
comparable social-demographic index, suggested that the stroke
death rates in North Macedonia are substantially higher than those
in other countries (Supplementary Figure 1B). Mortality after
ischemic strokes is observed frequently throughout the Balkan
peninsula (Supplementary Table 1). Ischemic stroke is the second
leading cause of death in North Macedonia.
PCD due to VAo stenosis is the second most common cause of
stroke.
8-10
Lifestyle factors, including smoking, alcohol consump-
tion, unhealthy diet, and sports, play a crucial role in the devel-
opment and progression of atherosclerosis and the risk of stroke.
25
In North Macedonia, a substantial proportion of the population
smokes
26
and, similar to the neighboring countries,
27,28
an active
lifestyle combined with a healthy diet is practiced only by a few
of the population. Consequently, the incidence of cardiovascular
disease and stroke has been increasing.
5,26,29
The physiological mechanisms leading to PCD are strongly
associated with the presence of atherosclerosis. Distal VA
atherosclerotic lesions have been reported; however, plaque de-
positions at the proximal segment have been observed most
often.
30-33
Table 1. Demographics and clinical characteristics (n¼20)
Variable Value
Age (years)
Full cohort 66.5 (46e77)
Male (n¼12) 61 (46e77)
Female (n¼8) 67.5 (52e77)
Weight (kg) 76.5 14.31
Height (m) 1.65 0.1
BMI (kg/m
2
) 28.2 4.86
Symptoms
Acute stroke 9 (45.0)
TIA 2 (10.0)
Vertigo 19 (95.0)
Syncope 4 (20.0)
Ataxia 5 (25.0)
Tinnitus 3 (15.0)
Scotoma 3 (15.0)
Diplopia 1 (5.0)
Comorbidity
Smoking 4 (20.0)
Diabetes mellitus 6 (30.0)
COPD 1 (5.0)
Arterial hypertension 20 (100)
Hyperlipidemia 18 (90.0)
Previous myocardial infarction 2 (10.0)
Peripheral artery disease 3 (15)
Coronary artery disease 5 (25.0)
Previous myocardial infarction 2 (10.0)
LMCA >50% stenosis 0 (0)
LAD >50% stenosis 5 (25.0)
Cx >50% stenosis 3 (15.0)
RCA >50% stenosis 4 (20.0)
LVEF (%) 54.1 7.8
Data presented as mean (range), mean standard deviation, or n(%).
BMI, body mass index; COPD, chronic obstructive pulmonary disease; Cx, circumflex ar-
tery; LAD, left anterior descending artery; LMCA, left main coronary artery; LVEF, left
ventricle ejection fraction; RCA, right coronary artery; TIA, transient ischemic attack.
Table 2. Preoperative Medical Therapy (n¼20)
Medication n(%)
Lipid-lowering therapy 15 (75)
Antiplatelet therapy (aspirin) 9 (45)
SAPT (clopidogrel) 7 (35)
DAPT 1 (5.0)
Antihypertensive therapy 18 (90.0)
DAPT, dual-antiplatelet therapy; SAPT, single-antiplatelet therapy.
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 5
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
We have described a minimally invasive surgery to resolve
extracranial VA stenosis causing PCD. Our procedure differs from
classic reports of VA surgery. We have opted for a 3-cm incision,
smaller than that originally reported for open surgical repair (5-7
cm).
34
In our experience, we were able to maintain an adequate
surgical view by stabilizing the incision site using the surgical
retractor, which supports recovery and allows for a more
aesthetic scar.
The corrective procedures we used consisted of resection and
anastomosis, endarterectomy, VA artery to subclavian artery
transposition, vein graft interposition techniques and bypass.
Several surgical techniques have been pioneered to treat VAo/V1
segment stenosis. A nonexhaustive list includes VA endarterec-
tomy,
35
VA to subclavian artery transposition,
36
transposition to
the common carotid artery,
10,37
vein bypass grafting from the
subclavian artery, and graft interposition techniques.
38,39
We typically combined multiple procedures, including trans-
position of the VA to the subclavian artery in 16 cases (Table 3).
Others have described VA transposition to the common carotid
artery as a successful technique to revascularize the posterior
circulation.
10,37
However, we have favored direct transposition of
the VA to a distal site on the subclavian artery to preserve the
native anatomy and posterior circulation ow characteristics as
much as possible. Furthermore, the technique we used is the
least invasive because it circumvents the necessity to clamp the
carotid artery. Mirroring our clinical observations, others have
reported that the technique is associated with long-term symp-
tom relief.
22
The indications for surgery account for the symptoms attribut-
able to PCD. Nevertheless, 1 case involved an asymptomatic
71-year-old man with signicant plague depositions at the right
VAo, a history of CVI, and >70% stenosis in both internal carotid
arteries. After careful evaluation, with consideration of the high
risk of posterior circulation stroke and the patients multiple
comorbidities, we performed graft interposition using the
saphenous vein.
40
Figure 2. (A) Computed tomography of the brain and (B) pre- and (C)
postoperative images of a patient who had undergone surgery twice to
resolve vertebrobasilar disease caused by significant calcification and
plaque deposition that had resulted in near-complete occlusion of the right
vertebral artery (VA). (D,E) Revascularization was achieved via
endarterectomy and longitudinal, transverse resection of the right
subclavian artery, followed by VA arterioplasty with the subclavian artery.
(F,G) The second procedure on the left VA was performed to resolve VA
ostium occlusion that had extended into the subclavian artery. (H,I) Left VA
pathology was treated using an autologous bypass bridge to the subclavian
artery.
Table 3. Surgical Details (n¼20)*
Variable n(%) or Median (IQR)
Operative findings
Stenosis 18 (90.0)
Occlusion 2 (10)
Kinking 2 (10)
Combined surgical corrective procedures
Vertebral artery to subclavian artery transposition 16 (80.0)
Resection and anastomosis 15 (75.0)
Vertebral artery thromboendarterectomy 10 (50.0)
Vein graft interposition techniques 4 (20.0)
Vein graft bypass 1 (5.0)
General anesthesia 20 (100)
Perioperative bleeding (<24 hours; mL) 15 (0e100)
IQR, interquartile range.
*Some patients had multiple vertebral artery ostium/V1 pathologies.
6www.SCIENCEDIRECT.com WORLD NEUROSURGERY,https://doi.org/10.1016/j.wneu.2020.11.041
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
The treatment options for posterior circulation ischemia caused
by VAo stenosis have increased in the previous decade.
6,33
Stenting
is feasible, despite the technical challenges related to the
morphology of the subclavian and proximal VAs. Nevertheless, 2
randomized trials
8,9
and preplanned pooled individual patient
data analysis evaluating VA stenting
41
failed to show evidence of a
benet for stroke prevention compared with medical therapy. The
results from recent single-center observational studies have
offered a promising outlook on the use of endovascular procedures
for VAo stenting.
8,9,42
Thus, stenting for extracranial VA stenosis
might be benecial; however, larger randomized controlled trials
are required to determine treatment success.
41
Collectively, both surgery and endovascular interventions can
lead to durable clinical outcomes, allowing for a personalized
revascularization strategy for PCD. Such a patient-centered
approach would substantially enhance the quality of care for
patients who have experienced stroke in North Macedonia.
However, endovascular proceduresforPCDarenotacommon
practice in North Macedonia. Advanced healthcare is still in
development, and, currently, experience is insufcient to
perform routine stenting of the VAs. The existing strategies used
bytheMinistryofHealthhavefailedtoimprovetheclinical
outcomes after ischemic stroke. A paucity of policies exist
focusedontheprovisionofstroke services or a national stroke
prevention program.
3,5
Our approach offers a treatment option for posterior circulation
ischemic events. The use of open surgical repair offers rapid relief
from neurological symptoms and prevents recurrent TIA/CVI. The
long-term results have been promising, with a total of 321 patient-
months, 15 patients had conrmed durable symptom-free status.
Figure 3. Mid-term survival, freedom from reoperation,
and reason for rehospitalization after vertebral artery
surgery. (A) Long-term survival (blue curve) and
event-free survival (red curve). Follow-up consisted of
321 patient-months (median, 18 months; interquartile
range, 5e24 months). Of 20 treated patients, 6 had
required rehospitalization during the follow-up period
for a cardiovascular pathology. Five had required
surgery. (B) Pie chart showing reasons for
rehospitalization; each readmission and the single
mortality case were scored as an event (red curve).
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 7
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
STUDY STRENGTHS AND LIMITATIONS
The results of the present study were inevitably associated with the
limitations of single-center observational studies.
43
Although we
have established that the procedure is clinically effective, long-
term CTA examinations of all patients to conrm adequate ow
characteristics would have beneted the study results. Nonethe-
less, the present case series has offered promising results and
guidance on how to manage posterior circulation ischemia in the
absence of well-established endovascular treatment options. Also,
the reported stroke recurrence-free rate and clinical outcomes
have been encouraging and on par with the results obtained from
neurosurgery center of excellence.
7,10,14,44
The observed relapse-
free survival rate was noteworthy; thus, the described technique
might become a valuable approach to curb the stroke pandemic
in North Macedonia.
CONCLUSIONS
The minimally invasive surgical repair of VAo/V1 stenosis is a safe
and clinically effective option to treat patients at high risk of
posterior ischemic events in developing countries, such as North
Macedonia. Our treatment approach represents a valuable alter-
native for patients in the absence of a nationwide effective stroke
prevention and treatment program.
CRediT AUTHORSHIP CONTRIBUTION STATEMENT
Riste Zimoski: Data curation, Investigation, Methodology, Valida-
tion, Writing - original draft, Writing - review & editing. Petar
Ugurov: Conceptualization, Investigation, Project administration,
Validation, Visualization, Writing - original draft. Lidija Veljanoska-
Kiridjievska: Investigation, Validation, Visualization. Nikola
Hristov: Supervision. Enver Idoski: Project administration, Super-
vision. Marko Gjorgon: Supervision, Writing - original draft. Neda
Milevska-Kostova: Conceptualization, Investigation, Writing - re-
view & editing. Rodney Alexander Rosalia: Conceptualization, Data
curation, Formal analysis, Investigation, Methodology, Project
administration, Resources, Software, Supervision, Validation,
Visualization, Writing - original draft, Writing - review & editing.
Zan Mitrev: Conceptualization, Investigation, Methodology, Project
administration, Resources, Supervision, Validation, Visualization,
Writing - original draft, Writing - review & editing.
ACKNOWLEDGMENTS
We thank Drs. Atanas Stojanov and Milan Klimkarov for data
collection and screening of medical history les. The single-center
registry containing all data can be shared by the editorial team on
reasonable request.
REFERENCES
1. Global Burden of Disease Network. Global Burden of
Disease Study 2017 (GBD 2017) Results. Seattle, WA:
Institute for Health Metrics and Evaluation; 2018.
2. Shah R, Wilkins E, Nichols M, et al. Epidemiology
report: trends in sex-specic cerebrovascular dis-
ease mortality in Europe based on WHO mortality
data. Eur Heart J. 2019;40:755-764.
3. Evaluation IfHMa. Available at: http://www.
healthdata.org/macedonia. Accessed September
1, 2020.
4. Budincevic H, Tiu C, Bereczki D, et al. Manage-
ment of ischemic stroke in Central and Eastern
Europe. Int J Stroke. 2015;10(suppl A100):125-127.
5. Stevens E, Emmett E, Wang Y, McKevitt C,
Wolfe C. The Burden of Stroke in Europe. London,
UK: Stroke Alliance for Europe; 2017.
6. Ausman JI, Liebeskind DS, Gonzalez N, et al.
A review of the diagnosis and management of
vertebral basilar (posterior) circulation disease.
Surg Neurol Int. 2018;9:106.
7. Berguer R, Flynn LM, Kline RA, Caplan L. Sur-
gical reconstruction of the extracranial vertebral
artery: management and outcome. J Vasc Surg.
2000;31(Pt 1):9-18.
8. Radak D, Babic S, Sagic D, et al. Endovascular
treatment of symptomatic high-grade vertebral
artery stenosis. J Vasc Surg. 2014;60:92-97.
9. Rangel-Castilla L, Gandhi S, Munich SA, et al.
Experience with vertebral artery origin stenting
and ostium dilatation: results of treatment and
clinical outcomes. J Neurointerv Surg. 2016;8:
476-480.
10. Rangel-Castilla L, Kalani MY, Cronk K,
Zabramski JM, Russin JJ, Spetzler RF. Vertebral
artery transposition for revascularization of the
posterior circulation: a critical assessment of
temporary and permanent complications and
outcomes. J Neurosurg. 2015;122:671-677.
11. Banerjee G, Stone SP, Werring DJ. Posterior cir-
culation ischaemic stroke. BMJ. 2018;361:k1185.
12. Simonetto M, DeSousa K, Campo N, Pandey V,
Koch S. Topography of vertebral artery origin
plaques: characteristics and determinants.
J Ultrasound Med. 2019;38:331-335.
13. Brasiliense LB, Albuquerque FC, Spetzler RF,
Hanel RA. Advances and innovations in revascu-
larization of extracranial vertebral artery. Neuro-
surgery. 2014;74(suppl 1):S102-S115.
14. Hanel RA, Brasiliense LB, Spetzler RF. Microsur-
gical revascularization of proximal vertebral artery:
a single-center, single-operator analysis. Neuro-
surgery. 2009;64:1043-1050 [discussion: 1051].
15. Babic S, Radak D. Letter to the editor: surgical
treatment of VA stenosis in the endovascular era.
J Neurosurg. 2015;123:1611.
16. Jacobs JP, Mavroudis C, Jacobs ML, et al. What is
operative mortality? Dening death in a surgical
registry database: a report of the STS Congenital
Database Taskforce and the Joint EACTS-STS
Congenital Database Committee. Ann Thorac Surg.
2006;81:1937-1941.
17. Aboyans V, Ricco J-B, Bartelink M-LEL, et al. 2017
ESC guidelines on the diagnosis and treatment of
peripheral arterial diseases, in collaboration with
the European Society for Vascular Surgery (ESVS):
document covering atherosclerotic disease of
extracranial carotid and vertebral, mesenteric,
renal, upper and lower extremity arteries.
Endorsed by the European Stroke Organization
(ESO), the Task Force for the Diagnosis and
Treatment of Peripheral Arterial Diseases of the
European Society of Cardiology (ESC), and the
European Society for Vascular Surgery (ESVS). Eur
Heart J. 2017;39:763-816.
18. World Medical Association. Declaration of Hel-
sinki: ethical principles for medical research
involving human subjects. JAMA. 2013;310:
2191-2194.
19. Uschold T, Abla AA, Wilson DA, McDougall CG,
Nakaji P. Intradural vertebral endarterectomy with
nonautologous patch angioplasty for refractory
vertebrobasilar ischemia: case report and litera-
ture review. Surg Neurol Int. 2014;5:166.
20. Sottiurai VS, Lyons R, Omlie W, et al. Combined
carotid endarterectomy and vertebral trans-
position or bypass for cerebral and vertebrobasilar
insufciency. Vasc Surg. 2000;34:137-146.
21. Spetzler RF, Hadley MN, Martin NA, Hopkins LN,
Carter LP, Budny J. Vertebrobasilar insufciency.
Part 1: microsurgical treatment of extracranial
vertebrobasilar disease. J Neurosurg. 1987;66:
648-661.
22. Kakino S, Ogasawara K, Kubo Y, et al. Clinical
and angiographic long-term outcomes of vertebral
arteryesubclavian artery transposition to treat
symptomatic stenosis of vertebral artery origin.
J Neurosurg. 2009;110:943-947.
23. Raheja A, Taussky P, Kumpati GS, Couldwell WT.
Subclavian-to-extracranial vertebral artery bypass
in a patient with vertebrobasilar insufciency: 3-
dimensional operative video. Oper Neurosurg.
2017;14:312.
24. Sundt TM Jr, Piepgras DG, Houser OW,
Campbell JK. Interposition saphenous vein grafts
8www.SCIENCEDIRECT.com WORLD NEUROSURGERY,https://doi.org/10.1016/j.wneu.2020.11.041
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
for advanced occlusive disease and large aneu-
rysms in the posterior circulation. J Neurosurg.
1982;56:205-215.
25. Tsivgoulis G, Safouris A, Kim DE, Alexandrov AV.
Recent advances in primary and secondary pre-
vention of atherosclerotic stroke. J Stroke. 2018;20:
417.
26. American Cancer Society. FYR MacedoniaTobacco
Atlas; 2020. Available at: https://tobaccoatlas.org/
country/fyr-macedonia/. Accessed May 1, 2020.
27. Bender M, Jusufovic E, Railic V, et al. High burden
of stroke risk factors in developing country: the
case study of Bosnia-Herzegovina. Mater Sociomed.
2017;29:277-279.
28. Potpara TS, Simovic S, Pavlovic N, et al. Stroke
prevention in elderly patients with non-valvular
atrial brillation in the BALKAN-AF survey. Eur J
Clin Invest. 2020;50:e13200.
29. Timmis A, Townsend N, Gale CP, et al. European
Society of Cardiology: cardiovascular disease sta-
tistics 2019. Eur Heart J. 2019;41:12-85.
30. Markus HS, van der Worp HB, Rothwell PM.
Posterior circulation ischaemic stroke and tran-
sient ischaemic attack: diagnosis, investigation,
and secondary prevention. Lancet Neurol. 2013;12:
989-998.
31. SSYLVIA Study Investigators. Stenting of symp-
tomatic atherosclerotic lesions in the vertebral or
intracranial arteries (SSYLVIA): study results.
Stroke. 2004;35:1388-1392.
32. Savitz SI, Caplan LR. Vertebrobasilar disease.
N Engl J Med. 2005;352:2618-2626.
33. Naylor AR, Ricco JB, de Borst GJ, et al. Editors
choice emanagement of atherosclerotic carotid
and vertebral artery disease: 2017 clinical practice
guidelines of the European Society for Vascular
Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:
3-81.
34. Edwards WH, Mulherin JL Jr. The surgical
reconstruction of the proximal subclavian and
vertebral artery. J Vasc Surg. 1985;2:634-639.
35. Cate WR Jr, Scott HW Jr. Cerebral ischemia of
central origin: relief by subclavian-vertebral artery
thromboendarterectomy. Surgery. 1959;45:19-31.
36. Ogawa A, Yoshimoto T, Sakurai Y. Treatment of
proximal vertebral artery stenosis: vertebral to
subclavian transposition. Acta Neurochir. 1991;112:
13-18.
37. Edwards WH, Edwards WH Jr. Vertebral-carotid
transposition. Semin Vasc Surg. 2000;13:70-73.
38. Zhang H, Zhao Y, Naha G, Hou C, Wang Z,
Yang X. Successful management of extracranial
vertebral artery aneurysm by articial vessel
reconstruction. World Neurosurg. 2018;116:249-254.
39. Vetter M, Iwanaga J, Choi PJ, Yilmaz E,
Oskouian RJ, Tubbs RS. A novel microsurgical
procedure for revascularization of the vertebral
artery. World Neurosurg. 2019;122:e302-e306.
40. Compter A, van der Worp HB, Algra A,
Kappelle LJ. Second Manifestations of Arterial
Disease (SMART) Study Group. Prevalence and
prognosis of asymptomatic vertebral artery origin
stenosis in patients with clinically manifest arte-
rial disease. Stroke. 2011;42:2795-2800.
41. Markus HS, Harsheld EL, Compter A, et al.
Stenting for symptomatic vertebral artery stenosis:
a preplanned pooled individual patient data
analysis. Lancet Neurol. 2019;18:666-673.
42. Chen L, Jiang Y, Hu F, He L, Zheng H. Endo-
vascular revascularization of nonacute symptom-
atic proximal extracranial vertebral artery
occlusion. World Neurosurg. 2020;134:39-44.
43. Bellomo R, Warrillow SJ, Reade MC. Why we
should be wary of single-center trials. Crit Care
Med. 2009;37:3114-3119.
44. Duan H, Mo D, Zhang Y, Zhang J, Li L. Carotid-
vertebral artery bypass with saphenous vein graft
for symptomatic vertebrobasilar insufciency.
Neurosurg Focus. 2019;46:E8.
Conflict of interest statement: Zan Mitrev is hospital director
at the Zan Mitrev Clinic. The remaining authors declare that
the article content was composed in the absence of any
commercial or financial relationships that could be construed
as a potential conflict of interest.
Presented as a preliminary analysis in poster format and
awarded third place prize at the Bulgarian Society for
Endovascular Therapy and International Association of
Endovascular Specialists Endovascular Academy 2019.
Received 10 June 2020; accepted 7 November 2020
Citation: World Neurosurg. (2020).
https://doi.org/10.1016/j.wneu.2020.11.041
Journal homepage: www.journals.elsevier.com/world-
neurosurgery
Available online: www.sciencedirect.com
1878-8750/ª2020 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 9
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
APPENDIX
Supplementary Table 1. Burden of Ischemic Stroke in Macedonia and the Balkans in 2017
Country
Death (n;%)
OR (95% CI); PValue (Fishers Exact Test; NMK vs. Comparator)All-Cause Ischemic Stroke
Macedonia (NMK) 19,111 2412 (12.62) NS
Albania 21,757 739 (3.40) 4.11 (3.78e7.28); <0.0001
Bosnia and Herzegovina 37,011 5365 (14.50) 0.85 (0.81e0.90); <0.0001
Bulgaria 107,619 12,809 (11.90) 1.07 (1.02e1.12); <0.0001
Croatia 51,211 3755 (7.33) 1.82 (1.73e3.19); 0.0051
Greece 120,258 8427 (7.01) 1.92 (1.83e2.01); <0.0001
Montenegro 6502 318 (4.90) 2.81 (2.49e3.17); <0.0001
Serbia 123,685 19,410 (15.69) 0.78 (0.74e0.81); <0.0001
Slovenia 19,904 1120 (5.63) 1.09 (1.07e1.11); <0.0001
CI, confidence interval; NMK, Republic of North Macedonia; NS, not significance; OR, odds ratio.
Data from the Global Burden of Disease Study 2017 Results.
1
9.e1 www.SCIENCEDIRECT.com WORLD NEUROSURGERY,https://doi.org/10.1016/j.wneu.2020.11.041
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
Supplementary Figure 1. (A) Top 10 causes of death in 2017
and the percentage of change from 2007 to 2017. The data
shown encompasses all ages. (B) Heat map showing top
10 causes of death and disability (disability-adjusted
life-years) for Republic of North Macedonia countrywide
analysis in 2017, which can be used to compare
disability-adjusted life-years across locations relative to the
group average. Comparison groups were chosen according
to the global burden of disease regional classifications,
known trade partnerships, and sociodemographic
indicators: blue, significantly lower than high-middle
sociodemographic index mean; gray, statistically
indistinguishable from sociodemographic index mean; red,
significantly greater than the sociodemographic index
mean (available at: http://www.healthdata.org/
macedonia
3
).
WORLD NEUROSURGERY -:---,-2020 www.journals.elsevier.com/world-neurosurgery 9.e2
DOING MORE WITH LESS
RISTE ZIMOSKI ET AL. SURGICAL REPAIR OF VERTEBRAL ARTERY OSTIUM STENOSIS
Article
Background. The relevance of the review is determined by the fairly high incidence of strokes in the vertebrobasilar region. Aim. To analyze the literature on occlusive-stenotic lesions of the vertebral arteries as the causes of ischemic strokes and methods of their treatment. Results. It has been established that the problem of ischemic strokes due to occlusive-stenotic lesions of the vertebral arteries is a poorly covered topic. Existing options for eliminating stenosis of the vertebral artery mouth have advantages and disadvantages, and vary depending on many factors. Conclusions. The most effective method of treating occlusive-stenotic lesions of the vertebral arteries, which cause the development of vertebrobasilar insufficiency, has not yet been finally determined. This emphasizes the need for further research to develop a pathogenetically based treatment algorithm for such patients.
Article
Full-text available
Aims: The 2019 report from the European Society of Cardiology (ESC) Atlas provides a contemporary analysis of cardiovascular disease (CVD) statistics across 56 member countries, with particular emphasis on international inequalities in disease burden and healthcare delivery together with estimates of progress towards meeting 2025 World Health Organization (WHO) non-communicable disease targets. Methods and results: In this report, contemporary CVD statistics are presented for member countries of the ESC. The statistics are drawn from the ESC Atlas which is a repository of CVD data from a variety of sources including the WHO, the Institute for Health Metrics and Evaluation, and the World Bank. The Atlas also includes novel ESC sponsored data on human and capital infrastructure and cardiovascular healthcare delivery obtained by annual survey of the national societies of ESC member countries. Across ESC member countries, the prevalence of obesity (body mass index ≥30 kg/m2) and diabetes has increased two- to three-fold during the last 30 years making the WHO 2025 target to halt rises in these risk factors unlikely to be achieved. More encouraging have been variable declines in hypertension, smoking, and alcohol consumption but on current trends only the reduction in smoking from 28% to 21% during the last 20 years appears sufficient for the WHO target to be achieved. The median age-standardized prevalence of major risk factors was higher in middle-income compared with high-income ESC member countries for hypertension {23.8% [interquartile range (IQR) 22.5-23.1%] vs. 15.7% (IQR 14.5-21.1%)}, diabetes [7.7% (IQR 7.1-10.1%) vs. 5.6% (IQR 4.8-7.0%)], and among males smoking [43.8% (IQR 37.4-48.0%) vs. 26.0% (IQR 20.9-31.7%)] although among females smoking was less common in middle-income countries [8.7% (IQR 3.0-10.8) vs. 16.7% (IQR 13.9-19.7%)]. There were associated inequalities in disease burden with disability-adjusted life years per 100 000 people due to CVD over three times as high in middle-income [7160 (IQR 5655-8115)] compared with high-income [2235 (IQR 1896-3602)] countries. Cardiovascular disease mortality was also higher in middle-income countries where it accounted for a greater proportion of potential years of life lost compared with high-income countries in both females (43% vs. 28%) and males (39% vs. 28%). Despite the inequalities in disease burden across ESC member countries, survey data from the National Cardiac Societies of the ESC showed that middle-income member countries remain severely under-resourced compared with high-income countries in terms of cardiological person-power and technological infrastructure. Under-resourcing in middle-income countries is associated with a severe procedural deficit compared with high-income countries in terms of coronary intervention, device implantation and cardiac surgical procedures. Conclusion: A seemingly inexorable rise in the prevalence of obesity and diabetes currently provides the greatest challenge to achieving further reductions in CVD burden across ESC member countries. Additional challenges are provided by inequalities in disease burden that now require intensification of policy initiatives in order to reduce population risk and prioritize cardiovascular healthcare delivery, particularly in the middle-income countries of the ESC where need is greatest.
Article
Full-text available
Aims: There have been substantial declines in cerebrovascular disease mortality across much of Europe, mirroring trends in deaths from cardiovascular disease as a whole. No study has investigated trends in cerebrovascular disease, and its subtypes within all European countries. This study aimed to examine sex-specific trends in cerebrovascular disease, and three of its sub-types: ischaemic stroke, haemorrhagic stroke, and subarachnoid haemorrhage (SAH), in Europe between 1980 and 2016. Methods and results: Sex-specific mortality data for each country of the World Health Organization (WHO) Europe region were extracted from the WHO global mortality database and analysed using Joinpoint software to examine trends. The number and location of significant joinpoints for each country by sex and subtype was determined using a log-linear model. The annual percentage change within each segment was calculated along with the average annual percentage change over the duration of all available data. The last 35 years have seen large overall declines in cerebrovascular disease mortality rates in the majority of European countries. While these declines have continued steadily in more than half of countries, this analysis has revealed evidence of recent plateauing and even increases in stroke mortality in a number of countries, in both sexes, and in all four geographical sub-regions of Europe. Analysis by stroke sub-type revealed that recent plateauing was most common for haemorraghic stroke and increases were most common for ischaemic stroke. Conclusion: These findings highlight the need for continued research into the inequalities in both current stroke mortality outcomes and trends across Europe, as well as the causes behind any recent plateauing of total cerebrovascular disease or its subtypes.
Article
Background: Atrial fibrillation (AF) is common amongst the elderly, but this group tends to be suboptimally treated. Limited data are available on the stroke prevention strategies in the elderly, especially in the Balkan region. Aim: We investigated the use of oral anticoagulant therapy (OAC) amongst elderly AF patients in clinical practice in the Balkan region. Method: A 12-week prospective snapshot survey (2014- 2015) of consecutive non-valvular AF patients was conducted in Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Romania and Serbia. Data were collected via an electronic case report form. Results: Of 2671 patients, 418 (15.6%) were ≥80 years old. Overall, OAC was used in 1965 patients (73.6%). Compared with younger patients, the elderly (age ≥80) had a higher mean CHA2 DS2 -VASc score (3.22±1.71 vs. 4.89±1.35, p<0.001) and more often a HAS-BLED score of ≥3 (n=198 [47.0%] vs. n=625 [27.3%], p<0.001), but were less likely to receive OAC (n=269 [64.4%] vs. n=1696 [75.3%], Odds Ratio [OR] 0.91; 95%CI 0.86-0.97, p=0.003). There was no significant association between OAC use and mean CHA2 DS2 -VASc (OR 0.86; 95%CI 0.75-1.00, p=0.053) or HAS-BLED score (OR 1.21; 95%CI 0.81-1.81, p=0.349) in the elderly. Conclusion: In the BALKAN-AF Survey, elderly AF patients were less likely to receive the guideline-adherent treatment despite their less favourable risk profile. Since OAC non-use among the elderly was not associated with increased HAS-BLED score, factors other than patients' risk profile could influence the implementation of guideline-adherent treatment for thromboprophylaxis in the elderly AF patients.
Article
Objective: To evaluate the feasibility, success rate, and safety of endovascular revascularization of nonacute symptomatic proximal extracranial vertebral artery occlusion (PEVAO). Methods: In a retrospective, single-center study, we analyzed clinical and imaging data from consecutive patients with PEVAO who underwent endovascular revascularization from June 2011 to March 2018. Results: The study enrolled 23 patients (mean age, 59 years; range, 42-77 years; 17 men). The rate of successful technical revascularization was 91.3% (n = 21), and the rate of complications was 4.3% (n = 1). At 3-month follow-up, the patients with successful endovascular revascularization of nonacute symptomatic PEVAO did not present any neurologic symptoms and computed tomography angiography did not show restenosis of the stent. Conclusions: Endovascular revascularization of nonacute symptomatic PEVAO is feasible and associated with a high rate of procedural success and low rate of procedural complications. A large, multicenter, randomized study is warranted to confirm the findings.
Article
Background: Symptomatic vertebral artery stenosis is associated with a high risk of recurrent stroke, with higher risks for intracranial than for extracranial stenosis. Vertebral artery stenosis can be treated with stenting with good technical results, but whether it results in improved clinical outcome is uncertain. We aimed to compare vertebral stenting with medical treatment for symptomatic vertebral stenosis. Methods: We did a preplanned pooled individual patient data analysis of three completed randomised controlled trials comparing stenting with medical treatment in patients with symptomatic vertebral stenosis. The primary outcome was any fatal or non-fatal stroke. Analyses were performed for vertebral stenosis at any location and separately for extracranial and intracranial stenoses. Data from the intention-to-treat analysis were used for all studies. We estimated hazard ratios (HRs) with 95% CIs using Cox proportional-hazards regression models stratified by trial. Findings: Data were from 354 individuals from three trials, including 179 patients from VIST (148 with extracranial stenosis and 31 with intracranial stenosis), 115 patients from VAST (96 with extracranial stenosis and 19 with intracranial stenosis), and 60 patients with intracranial stenosis from SAMMPRIS (no patients had extracranial stenosis). Across all trials, 168 participants (46 with intracranial stenosis and 122 with extracranial stenosis) were randomly assigned to medical treatment and 186 to stenting (64 with intracranial stenosis and 122 with extracranial stenosis). In the stenting group, the frequency of periprocedural stroke or death was higher for intracranial stenosis than for extracranial stenosis (ten (16%) of 64 patients vs one (1%) of 121 patients; p<0·0001). During 1036 person-years of follow-up, the hazard ratio (HR) for any stroke in the stenting group compared with the medical treatment group was 0·81% CI 0·45-1·44; p=0·47). For extracranial stenosis alone the HR was 0·63 (95% CI 0·27-1·46) and for intracranial stenosis alone it was 1·06 (0·46-2·42; pinteraction=0·395). Interpretation: Stenting for vertebral stenosis has a much higher risk for intracranial, compared with extracranial, stenosis. This pooled analysis did not show evidence of a benefit for stroke prevention for either treatment. There was no evidence of benefit of stenting for intracranial stenosis. Stenting for extracranial stenosis might be beneficial, but further larger trials are required to determine the treatment effect in this subgroup. Funding: None.
Article
OBJECTIVE Symptomatic steno-occlusion of the proximal vertebral artery (VA) or subclavian artery (ScA) heralds a poor prognosis and high risk of stroke recurrence despite medical therapy, including antiplatelet or anticoagulant drugs. In some cases, the V2 segment of the cervical VA is patent and perfused via collateral vessels. The authors describe 7 patients who were successfully treated by external carotid artery (ECA)-saphenous vein (SV)-VA bypass.METHODS Seven cases involving symptomatic patients were retrospectively studied: 3 cases of V1 segment occlusion, 2 cases of severe in-stent restenosis in the V1 segment, and 2 cases of occlusion of the proximal ScA. All patients underwent ECA-SV-VA bypass. The ECA was isolated and retracted, and the anterior wall of the transverse foramen was unroofed. The VA was exposed, and then the 2 ends of the SV were anastomosed to the VA and ECA in an end-to-side fashion.RESULTSSurgical procedures were all performed as planned, with no intraoperative complications. There were 2 postoperative complications (severe laryngeal edema in one case and shoulder weakness in another), but both patients recovered fully and measures were taken to minimize laryngeal edema and its effects in subsequent cases. All patients experienced improvement of their symptoms. No new neurological deficits were reported. Postoperative angiography demonstrated that the anastomoses were all patent, and analysis of follow-up data (range of follow-up 12-78 months) revealed no further ischemic events in the vertebrobasilar territory.CONCLUSIONS The ECA-SV-VA bypass is a useful treatment for patients who suffer medically refractory ischemic events in the vertebrobasilar territory when the proximal part of the VA or ScA is severely stenosed or occluded but the V2 segment of the cervical VA is patent.
Article
Objective A broad armamentarium of microsurgical techniques affords flexibility to surgeons when choosing a procedure that is best tailored to fit the anatomy of an individual. Herein, we report on the feasibility of using the deep cervical artery (DCA) to revascularize the vertebral artery (VA) via a DCA-V3 bypass graft. Methods Fourteen DCAs from 7 injected cadaveric heads were located and traced. The diameter of the main trunk of the DCA was measured bilaterally at the C3 level. The proximal vertebral branches of each DCA were then severed and the main trunk of the DCA was transposed superiorly onto the V3 segment of the VA, which was also exposed bilaterally. Results The DCA was identified and traced bilaterally on all specimens. The diameter of the main trunk of the DCA at the C3 level ranged from 1.03 to 2.79 mm. The mean diameter of the main trunk of the DCA at this level was found to be 1.52 ± 0.60 mm for the right side and 1.46 ± 0.54 mm for the left side. After releasing the proximal vertebral branches of the DCA, all arteries were able to be transposed to the ipsilateral VA. Conclusions Based on the mean diameter of the DCA reported in extant literature and this study, the blood flow volume of the DCA makes it a viable candidate to bypass the proximal VA.
Article
Background Atherosclerotic plaques located at the vertebral artery ostium (VAo) are a mechanism for posterior circulation stroke, but little is known about VAo plaque topography and formation. In this study, we describe the topography of atherosclerotic plaques involving the origin of the vertebral artery (VA). Methods Cross‐sectional analyses of extracranial duplex studies were performed, and VAo plaques were classified based on their topography in 3 groups: (1) exclusively at the VA ostium; (2) predominantly subclavian, with extension into the vertebral ostium; and (3) predominantly ostial, with extension into the subclavian artery). Chi‐square and analysis of variance tests were performed to investigate the association between VAo plaque topography and continuous and categorical variables, respectively. Results A total of 99 of 481 (21%) ultrasound duplex studies showed VAo plaques. The majority of the plaques (60%) were found to extend from the subclavian to the ostium. Plaques occurred more frequently at the medial wall of the VAo. No vascular risk factors were associated with plaque formation; however, women were more likely to have plaques involving predominantly or exclusively the VAo (P = .004). Conclusions We describe 3 different patterns of VAo involvement in patients with ostial atherosclerotic VA disease. VAo plaques occurred almost exclusively at the medial wall of the vessel. Women had more plaques involving predominantly the origin. Prospective studies are needed to investigate the clinical significance of these findings.
Article
Background: Unruptured extracranial vertebral artery (VA) aneurysms are uncommon and have rarely been described with treatment options. Case description: Here we report the successful reconstruction of an asymptomatic extracranial left VA aneurysm highlighting the treatment for extracranial VA aneurysm and the superiority of hybrid operating room in cerebral vascular diseases. The case reported a 57-year-old female who suffered an extracranial left VA aneurysm. MRA showed bilateral vertebral arteries as co-dominant in the vertebrobasilar system. Digital subtraction angiography demonstrated that the fusiform aneurysm (18.7mm × 15.4mm) was present at the proximal part of the left vertebral artery. Aneurysm resection and vascular graft reconstruction were performed in the hybrid operating room. And a successful outcome was achieved in the 6-months follow-up. Conclusions: Extracranial VA aneurysm in V1 segment can be well treated with an open surgery using prosthetic graft. Preserving the function of affected vertebral artery should always be a point of concern.